VTR· Real Estate› REIT - Healthcare Facilities

Ventas, Inc.

Stage 3 · Topping · week 4

As of Oct 22, 2026, Ventas is in Stage 3, the topping phase, now in week 4 (since Sep 29, 2026). It closed at $86.99, 12.9% below its 52-week high and above its 200-day average, which is rising.

Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. More about the company

$86.99

+1.89% today

$44.6B · Large cap

Market Neutral — Building

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is VTR early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 30w

S2 60w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 2w → S3 2w → S4 9w → S1 4w → S2 10w → S3 4w → S4 6w → S1 1w → S2 30w → S3 11w → S2 12w → S3 11w → S2 60w → S3 3w current

Total tracked: 166 weeks across 14 stage runs.

VTR among REIT - Healthcare Facilities5th of 17 by relative strength

All 17 →

Stocks in REIT - Healthcare Facilities ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	DHCDiversified Healthcare Trust	Stage 3 · wk 9	94	−3.1%
2	WELLWelltower Inc.	Stage 3 · wk 3	80	+3.3%
3	LTCLTC Properties, Inc.	Stage 2 · wk 14	77	+2.3%
4	AHRAmerican Healthcare REIT, Inc.	Stage 3 · wk 4	76	+3.8%
5	VTRVentas, Inc.	Stage 3 · wk 4	74	+1.0%
6	OHIOmega Healthcare Investors, Inc.	Stage 3 · wk 4	71	+0.3%
7	STRWStrawberry Fields REIT, Inc.	Stage 3 · wk 3	69	−6.0%
8	SBRASabra Health Care REIT, Inc.	Stage 3 · wk 3	66	−0.5%

vs 52W High

-12.9%

$68.10 lo$99.93 hi

12.9% below 52W high, weakening from peak

The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.

Stage Maturity

Week 4

1w13w26w

Week 4, early distribution

How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.

vs 200 DMA

1.9%

200 DMA: $85.37 · rising

Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.

Rel Volume

0.78x

vs 50-day avg

Volume spikes on down days during Stage 3 signal distribution, with institutions exiting. Stage analysis reads that as a warning against new long positions.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+1.0%

-12.9%

+6.1%

YTD

+14.6%

+26.9%

Scan Membership

Breakout Watch

Latest: 2025-02-27

9 appearances in last 60 days. First seen: 2018-11-20.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S3

Wk 4 · Vol 0.78x

2026-10-21S3

Wk 4 · Vol 0.41x

2026-10-20S3

Wk 4 · Vol 0.63x

2026-10-19S3

Wk 3 · Vol 0.64x

2026-10-16S3

Wk 3 · Vol 1.08x

2026-10-15S3

Wk 3 · Vol 1.20x

2026-10-14S3

Wk 3 · Vol 1.12x

2026-10-13S3

Wk 3 · Vol 1.14x

2026-10-12S3

Wk 2 · Vol 1.36x

2026-10-09S3

Wk 2 · Vol 1.15x

2026-10-08S3

Wk 2 · Vol 1.29x

2026-10-07S3

Wk 2 · Vol 1.17x

Moving averages & range

50 DMA

$87.61

200 DMA

$85.37

52W High

$99.93

52W Low

$68.10

5D Low

$84.51

Resistance levels (recent highs)

20d High

$86.99

60d High

$93.27

120d High

$99.93

250d High

$99.93

Next resistance

+7.2%

to 60d High

P/E (TTM)

161.1

Forward 110.1

Earnings Growth (YoY)

-6.7%

Revenue +21.7%

ROE

+2.0%

Profit margin +4.1%

Dividend Yield

2.44%

P/B 3.0

Ventas: quick answers

What stage is Ventas in?

As of Oct 22, 2026, Ventas (VTR) is in Stage 3, the topping phase. It entered Stage 3 on Sep 29, 2026 and is in week 4. What the four stages mean

Is Ventas in an uptrend?

Its uptrend has stalled. Ventas is in Stage 3, the topping phase that follows an advance. It trades 1.9% above its 200-day average, which is rising.

How far is Ventas from its 52-week high?

Ventas closed at $86.99 on Oct 22, 2026, 12.9% below its 52-week high of $99.93. Its 52-week low is $68.10.

How has Ventas performed over the past year?

As of Oct 22, 2026, Ventas is up 26.9% over the past year and up 14.6% so far in 2026.

Which sector and industry is Ventas in?

Ventas is in the REIT - Healthcare Facilities industry, part of the Real Estate sector.

About this companyReal Estate· REIT - Healthcare Facilities

Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.